Progress in the diagnosis, prevention, and treatment of pertussis

Current Infectious Disease Reports

Volumn 5, Issue 3, 2003, Pages 213-219

  Munoz, Flor M ^a   Keitel, Wendy A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIUM ANTIBODY; BORDETELLA VIRULENCE FACTOR; CLARITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; FIMBRIA PROTEIN; HEMAGGLUTININ; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; MACROLIDE; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DRUG TOLERABILITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION SENSITIVITY; INTERMETHOD COMPARISON; NONHUMAN; PATHOGENESIS; PERTUSSIS; POLYMERASE CHAIN REACTION; PYLORUS STENOSIS; REVIEW; SERODIAGNOSIS; SKIN MANIFESTATION; TREATMENT PLANNING;

EID: 7744229313     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-003-0076-9     Document Type: Review

References (45)

1. Centers for Disease Control and Prevention: Pertussis vaccination: use of acellular pertussis vaccines among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997, 46:RR-7.
2. American Academy of Pediatrics, Committee on Infectious Diseases: Recommended childhood immunization schedule United States, 2002. Pediatrics 2003, 111:212-216.
3. Centers for Disease Control and Prevention: Pertussis - United States, 1997-2000. MMWR 2002, 51.
4. Christopher FL, Hepburn MJ, Frolichstein RA: Pertussis in a military and military beneficiary population: case series and review of the literature. Mil Med 2002, 167:215-218.
5. Skowronski DM, De Serres G, MacDonald D, et al.: The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002, 185:1448-1453.
6. Galanis E, King A, Varughese P: The changing age and seasonal profile of pertussis in British Columbia, not Canada. J Infect Dis 2002, 186:1537-1538.
7. Gilberg S, Njamkepo E, Du Chatelet I, et al.: Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J Infect Dis 2002, 186:415-418.
8. Crowcroft NS, Andrews N, Rooney C, et al.: Deaths from pertussis are underestimated in England. Arch Dis Child 2002, 86:336-338.
9. Lin M, Roche P, Spencer J, et al.: Australia's notifiable disease status, 2000. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2002, 26: 18-203.
10. Spearing NM, Horvath RL, McCormack JG: Pertussis: adults as a source in health care setting. Med J Aust 2002, 177: 68-569.
11. Wang J, Yang Y, Li J, et al.: Infantile pertussis rediscovered in China. Emerg Infect Dis 2002, 8:859-861.
12. Hardwick TH, Cassiday P, Weyant RS, et al.: Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis 2002, 8:44-49.
13. Van Loo IH, Mooi FR: Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 2002, 148:2011-2018.
14. Centers for Disease Control and Prevention: Pertussis Deaths - United States, 2002. MMWR 2002, 51:28.
15. Pertussis in Texas. Texas Department of Health; 2002.
16. Poynten M, Hanlon M, Irwig L, Gilbert G L, et al.: Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection Epidemiol Infect 2002, 128:161-167.
17. Guidelines for the Control of Pertussis Outbreaks. Atlanta: Centers for Disease Control; 2000.
18. Cloud JL, Hymas W, Carroll KC: Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. J Clin Microbiol 2002, 40:3838-3840.
19. Lievano FA, Reynolds MA, Waring AL, et al.: Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 2002, 40:2801-2805.
20. Sloan LM, Hopkins MK, Mitchell PS, et al.: Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol 2002, 40:96-100.
21. Kosters K, Reischl U, Schmetz J, et al.: Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 2002, 40: 719-1722.
22. Chan EL, Antonishyn N, McDonald R, et al.: The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch Pathol Lab Med 2002, 126:173-176.
23. Taranger J, Trollfor B, Lagergard T, et al.: Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000, 181:1010-1013.
24. Centers for Disease Control and Prevention: Notice to readers: Food and Drug Administration approval of fifth acellular pertussis vaccine for use among infants and young children - United States, 2002. MMWR 2002, 51:26.
25. Greenberg DP, Pickering LK, Senders S, et al.: Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy. Pediatrics 2002, 109:666-672.
26. Halperin SA, Smith B, Russell M, et al.: Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J 2000, 19:276-283.
27. Jackson LA, Carste BA, Malais D, Froeschle J: Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids Pediatr Infect Dis J 2002, 21:781-786.
28. Keitel WA: Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 1999, 28:S118-S123.
29. Ward J, APERT Study Group: Pertussis epidemiology and acellular pertussis vaccine efficacy in older children and adults: NIH APERT multicenter pertussis trial [abstract]. Pediatr Res 2001, 49:4.
30. Canadian immunization guide. Health Canada National Advisory Committee on Immunization. 2002:169-176.
31. Halperin SA, Smith B, Russell M: An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000, 18:1312-1319.
32. Obaro SK, Enwere GC, Deloria M, et al.: Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 2002, 21:940-947.
33. Zepp F, Schuind A, Meyer C, et al.: Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics 2002, 109:e58.
34. Avdicova M, Prikazsky V, Hudeckova H, et al.: Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV- IPV /Hib vaccine compared to separate concomitant injections of DTPa- IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule. Eur J Pediatr 2002, 161:581-587.
35. Greenberg DP, Wong K, Partridge S, et al.: Safety and immunogenicity of a combination diphtheria-tetanus toxoids- acellular pertussis-hepatitis b vaccine administered at two, four and six months of age compared with monovalent hepatitis b vaccine administered at birth, one month and six months of age. Pediatr Infect Dis J 2002, 21:769-777.
36. Halperin BA, Halperin SA, McGrath P, et al.: Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae type b conjugate and hepatitis b vaccines in infants from birth to six months of age. Pediatr Infect Dis J 2002, 21: 99-405.
37. Pichichero ME, Blatter MM, Reisinger KS, et al.: Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-haemophilus influenzae type b combination vaccination. Pediatr Infect Dis J 2002, 21:854-859.
38. Nicol M, Huebner R, Mothupi R, et al.: Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial. Pediatr Infect Dis J 2002, 21:138-141.
39. Aoyama T, Sunakawa K, Iwata S, et al.: Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin J Pediatr 1996, 129:761-764.
40. Lebel M, Mehra S: Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr Infect Dis J 2001, 20:1149-1154.
41. Lewis K, Saubolle MA, Tenover FC, et al.: Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 1995, 14:388-391.
42. Korgenski EK, Daly JA: Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the intermountain west region of the United States. J Clin Microbiol 1997, 35:2989-2991.
43. Wilson KE, Cassiday PK, Popovic T, Sanden GN: Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. J Clin Microbiol 2002, 40:2942-2944.
44. Hill BC, Baker CN, Tenover FC: A Simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol 2000, 38:1151-1155.
45. Steinberg JM, Srugo I: Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids Arch Pediatr Adolesc Med 2002, 156:1057-1058.